Showing 1 - 20 results of 5,619 for search '(( using ((low decrease) OR (fold decrease)) ) OR ( a ((latest decrease) OR (marked decrease)) ))', query time: 0.69s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer by Ben J. Haines (22458462)

    Published 2025
    “…The efficacy of radiation therapy is limited by low oxygen tension within solid tumors. Papaverine and some derivatives were previously shown to inhibit mitochondrial complex 1 and decrease oxygen consumption, reversing hypoxia and radiosensitizing model tumors. …”
  5. 5

    Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer by Ben J. Haines (22458462)

    Published 2025
    “…The efficacy of radiation therapy is limited by low oxygen tension within solid tumors. Papaverine and some derivatives were previously shown to inhibit mitochondrial complex 1 and decrease oxygen consumption, reversing hypoxia and radiosensitizing model tumors. …”
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Data Sheet 1_Persistent lymphopenia after kidney transplantation: increased mortality and decreased homeostatic mechanisms.docx by Yun Liang (383275)

    Published 2025
    “…Mass cytometry immunophenotyping at 3 years showed that B cells, NK cells and all T cell subsets (CD4, CD8, naïve, memory, etc.) decreased with decreasing lymphocyte counts. This included fewer recent thymic emigrants, naïve T cells, and stem-cell like memory T cells (T<sub>SCM</sub>), suggesting an impaired homeostasis of peripheral T cells. …”
  16. 16
  17. 17

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…F-53B also induced Parkinson’s disease (PD)-like disorders including dyskinesia (incidence: 22.8–27.9%), dopaminergic neuronal damage (neuritic blebbings and broken neurites) and decreased dopamine levels (15.2–28.1%), increased abundance (1.3–1.4 fold) and aggregation of α-synuclein. …”
  18. 18

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…F-53B also induced Parkinson’s disease (PD)-like disorders including dyskinesia (incidence: 22.8–27.9%), dopaminergic neuronal damage (neuritic blebbings and broken neurites) and decreased dopamine levels (15.2–28.1%), increased abundance (1.3–1.4 fold) and aggregation of α-synuclein. …”
  19. 19

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…F-53B also induced Parkinson’s disease (PD)-like disorders including dyskinesia (incidence: 22.8–27.9%), dopaminergic neuronal damage (neuritic blebbings and broken neurites) and decreased dopamine levels (15.2–28.1%), increased abundance (1.3–1.4 fold) and aggregation of α-synuclein. …”
  20. 20

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…F-53B also induced Parkinson’s disease (PD)-like disorders including dyskinesia (incidence: 22.8–27.9%), dopaminergic neuronal damage (neuritic blebbings and broken neurites) and decreased dopamine levels (15.2–28.1%), increased abundance (1.3–1.4 fold) and aggregation of α-synuclein. …”